Hospitals enjoy third-quarter recovery
After suffering a financial swoon a year ago, Indiana’s hospitals look like they’re back on firmer—though not rock-solid—footing.
Life Science & Biotech
Articles
Are workplace wellness programs worth it?
Believe it or not, wellness is now a minefield for businesses. The Equal Employment Opportunity Commission has taken up three lawsuits against companies because of their wellness programs. And new research finds that wellness programs probably cost employers money.
Obamacare’s Cadillac tax forcing Indiana employers to tap brakes on health benefits
No Hoosier employers want to pay Obamacare’s 40 percent excise tax on health benefits, which hits in 2018. So they are embracing high-deductible plans and putting more responsibility for health care spending on workers.
Report: Half of hospital systems could disappear in next decade
Deloitte consultants say hospitals are about to go the way of department stores, airlines and banks by clustering into fewer and fewer competitors. There’s plenty of evidence from Indiana to support that theory.
BioCrossroads attracts another $2.4M from Fairbanks Foundation
The money is designed to further the life sciences group’s work on such initiatives as the Indiana Biosciences Research Institute and the Indiana Health Information Exchange.
Hospital cost-cutting forces Blood Center to lay off workers, change leaders
Facing the loss of key hospital contracts, the Indiana Blood Center cut 27 jobs on Friday, announced the retirement of its CEO and said it will join a consortium of Midwest blood centers.
Data show 1 in 5 uninsured Hoosiers gained health coverage this year
Even without Medicaid expansion, Obamacare appears to have substantially reduced the more than 900,000 Hoosiers that go without health insurance during a year.
Obamacare exchange 2.0: Anthem far from the cheapest plan
There are more choices and better deals in the 2015 Obamacare exchange, but if you want the same coverage as last year, it’s going to cost you more.
Top 4 questions for Hoosier health care after GOP takes control of Congress
On Obamacare, the new Republican-controlled Congress should “leave the façade of the building and then demolish the inside of it,” according to one GOP leader. If Republicans take that approach, here are four things that could change in the next two years.
Biotech firm Algaeon switches gears, stays in Indy
After planning a move to Westfield, Algaeon Inc. has instead leased new space in Indianapolis for a research and production facility. Planning 25 hires, it is seeking a tax break from the city on $4.9 million in new equipment.
Initiative raises $1M to boost science-based ag businesses
AgriNovus, the newest initiative of the Central Indiana Corporate Partnership, wants to help Hooosier ag companies play a leading role in figuring out to feed the world’s fast-growing population.
Will strip mall medicine help or hurt hospital systems?
Retail clinics and urgent care centers are proliferating. That could expand the market for health care. But if consumers decide instead to make strip malls the front door to their health care—rather than traditional physician offices—the hospital systems could see their market shares waning.
Indy-based Vertellus acquires chemical maker in U.K.
The addition of Pentagon Chemicals UK Ltd. could add at least $75 million in revenue to the top line of Vertellus Speciaties Inc., one of the largest private firms in Indianapolis.
Research firm Covance to be acquired in $6.1 billion deal
Covance manages clinical trials for drugmakers including locally-based Eli Lilly and Co. It employs about 1,500 workers in Indianapolis and Greenfield.
Why small Hoosier employers aren’t dropping their health plans—yet
Obamacare's community rating rules would give 25-percent-off coupons to boomers while sticking millennials with a 75-percent surcharge, according to recent data from employer health plans.
Zimmer to become Zimmer Biomet after acquisition
Orthopedic device maker Zimmer said Thursday it will be called Zimmer Biomet after its combination with privately held competitor Biomet.
BioCrossroads: Life sciences funding hit $25B in past decade
In the decade after the founding of the BioCrossroads initiative, money spent on life sciences research and companies more than doubled, according to a report released Thursday by the Indianapolis-based life sciences business development group.
Hoosier medical device companies look off shore
Slowing domestic growth pushes executives to brighter markets.
Eli Lilly donates $12.7 million to United Way
The donation represents the giving of employees and retirees of Lilly and Elanco Animal Health in the U.S. and Puerto Rico, plus a matching contribution from the Lilly Foundation.
Lechleiter: It’s morning at Eli Lilly
Lilly CEO John Lechleiter kicked off the company’s quarterly conference call with investors and analysts by declaring an end to the “unprecedented challenge” that Lilly lived through the past four years.